RESOLUTE China RCT

NACompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

June 30, 2017

Conditions
Ischemic Heart DiseaseStenotic Coronary LesionCardiovascular DiseasesArteriosclerosisCoronary Artery Disease
Interventions
DEVICE

Taxus Liberte Paclitaxel-Eluting Coronary Stent System

Taxus Liberte Paclitaxel-Eluting Coronary Stent System Implantation

DEVICE

Resolute Zotarolimus-Eluting Coronary Stent System

Resolute Zotarolimus-Eluting Coronary Stent System Implantation

Trial Locations (4)

100029

An Zhen Hospital, Beijing

100037

Beijing Fu Wai Hospital, Beijing

510080

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

710061

First Affiliated Hospital of Medical College of XI'AN Jiaotong University, Xi'an

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Medtronic Vascular

INDUSTRY

NCT01334268 - RESOLUTE China RCT | Biotech Hunter | Biotech Hunter